Citadel Advisors - GENETIC TECHNOLOGIES LTD ownership

GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R208. A total of 13 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of GENETIC TECHNOLOGIES LTD
ValueSharesWeighting
Q2 2019$27,000
-6.9%
45,157
+37.7%
0.00%
Q1 2019$29,000
+61.1%
32,787
-3.4%
0.00%
Q4 2018$18,000
+38.5%
33,957
+194.0%
0.00%
Q3 2018$13,000
-31.6%
11,551
-35.4%
0.00%
Q1 2018$19,000
-17.4%
17,869
-30.1%
0.00%
Q2 2017$23,000
+76.9%
25,580
+131.1%
0.00%
Q1 2017$13,000
-31.6%
11,069
+4.0%
0.00%
Q3 2016$19,000
-50.0%
10,648
-34.9%
0.00%
Q1 2016$38,000
+65.2%
16,355
+28.6%
0.00%
Q3 2015$23,000
-47.7%
12,717
-11.2%
0.00%
Q2 2015$44,000
-79.5%
14,319
-64.9%
0.00%
Q1 2015$215,00040,7380.00%
Other shareholders
GENETIC TECHNOLOGIES LTD shareholders Q1 2017
NameSharesValueWeighting ↓
Alpine Global Management, LLC 28,437$30,0000.01%
Virtu Financial LLC 37,505$39,0000.00%
Renaissance Technologies 982,980$1,022,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 2,750$3,0000.00%
JANE STREET GROUP, LLC 13,527$14,0000.00%
UBS Group AG 3,398$3,0000.00%
CITIGROUP INC 300$00.00%
MORGAN STANLEY 1,520$2,0000.00%
Financial Architects, Inc 350$00.00%
Cambridge Investment Research Advisors, Inc. 12,000$12,0000.00%
View complete list of GENETIC TECHNOLOGIES LTD shareholders